Amgen to buy another drugmaker, Alantos, for $300 million

06/6/2007 | Red Herring

Amgen says it has agreed to buy Alantos Pharmaceuticals for $300 million, gaining access to drugs for treating diabetes and inflammatory diseases. The acquisition is part of a buying spree by Amgen, which just announced a similar purchase of Ilypsa.

View Full Article in:

Red Herring

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI